Prosaptide TX14: Myelos began U.S. Phase II placebo-controlled testing

Myelos Neurosciences Corp., San Diego, Calif. Product: Prosaptide TX14(A) derivative of neurotrophic factor prosaposine Indication: Treat pain syndromes and peripheral neuropathies Status: Myelos bega...